GNOM ETF largest country is US at 84.3% as of Aug 4, 2026

GNOM ETF largest country is US at 84.3% as of Aug 4, 2026
$66.77
See how much of GNOM you already own
Just $25 once·$69/mo·Download sample
X-ray my portfolio free

US is GNOM's largest country exposure at 84.3% of the fund as of Aug 4, 2026. GNOM is Global X Genomics & Biotechnology ETF.

Top Countries

#CountryRegionAllocation
1US
Global
84.34%
2Netherlands
Europe
5.81%
3Switzerland
Europe
3.23%
4Germany
Europe
2.89%
5Hong Kong
Asia-Pacific
2.36%
6United Kingdom
Europe
1.38%

GNOM ETF Geographic Allocation

GNOM geographic allocation spans US (84.3%), Netherlands (5.8%), Switzerland (3.2%), Germany (2.9%), Hong Kong (2.4%). The fund covers 3 regions.

GNOM country exposure helps investors assess international diversification and geopolitical risk. GNOM sectors alongside geography give a fuller picture of portfolio allocation.

GNOM ETF Geographic Exposure

Market Development Overview

Developed Markets5 countries
15.7%
Emerging Markets1 country
84.3%

Regional Allocation

Global
84.3%
46 holdings
Europe
13.3%
5 holdings
Asia-Pacific
2.4%
1 holding

Country Breakdown (Top 20)

CountryRegionStatusAllocation
USGlobalEmerging
84.34%
NetherlandsEuropeDeveloped
5.81%
SwitzerlandEuropeDeveloped
3.23%
GermanyEuropeDeveloped
2.89%
Hong KongAsia-PacificDeveloped
2.36%
United KingdomEuropeDeveloped
1.38%